Eli Lilly & Company (LLY)
Email Confirmation
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
Dr. John C. Lechleiter, Ph.D., President/COO/Director/CEO
Lilly Corporate Center
Indianapolis, IN 46285
US
Map it ![]()
Overview
The Company discovers, develops, manufactures and sells products in one segment of pharmaceutical products.
Press Releases
-
Sucampo Pharmaceuticals Appoints Andrew J. Ferrara to its Board of Directors Jul-22-2008, 08:00AM EDT
-
The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds Jul-16-2008, 08:00AM EDT
-
Lilly Partners With the National Council of La Raza to Fight Chronic Disease Jul-13-2008, 09:00AM EDT
-
Lilly Supports Industry Code on Interactions with Healthcare Professionals Jul-10-2008, 09:00AM EDT
-
Enlight Biosciences Launched in Collaboration with Merck & Co., Inc., Pfizer, and Eli Lilly Jul-10-2008, 07:30AM EDT
News From Around the Web
News
-
Eli Lilly profit increases 44 percent in 2nd qtr on rising sales, but cuts profit forecast
(Newsday)Jul 24 2008 -
Mixed Start May Await Stocks on Wall Street
(The Street)Jul 24 2008 -
Eli Lilly profit increases 44 percent in 2nd qtr on rising sales; but cuts profit forecast
(Baltimore Sun)Jul 24 2008 -
Jul 24 2008
-
Earnings Preview: Eli Lilly & Co.
(SeekingAlpha)Jul 23 2008 -
7 Dividend Stocks for a Bear Market
(Motley Fool)Jul 22 2008 -
Pfizer, AstraZeneca, Merck, Eli Lilly, and Others Explain Their Strategies in Storing and Supplying Compounds
(PharmaLive)Jul 22 2008 -
Jul 22 2008
-
SGX Pharm Hldrs To Vote Aug 20 On Eli Lilly Deal >SGXP LLY
(Wall Street Journal)Jul 22 2008
Blogs
-
Is Pfizer's Viagra "Sagging" With The Economy?
(CNBC: Pharmas Market with Mike Huckman)Jul 23 2008
Employees
Number of Employees: 40,600
Revenue per Employee: $426,246
Top Executives
Robert A. Armitage, Senior VP/General Counsel
Bryce D. Carmine, Executive VP, Divisional
Alex M. Azar, II, Senior VP, Divisional
Dr. Steven M. Paul, M.D., Executive VP, Divisional
Derica W. Rice, CFO/Senior VP
Arnold C. Hanish, Chief Accounting Officer
Gino Santini, Divisional Senior VP
Anthony J. Murphy, Ph.D., Divisional Senior VP
Frank M. Deane, Ph.D., President, Divisional
Board of Directors
Michael L. Eskew, Director
Dr. Franklyn G. Prendergast, M.D., Ph.D., Director
Dr.Karen N. Horn, Ph.D., Director
Dr.Alfred G. Gilman, M.D., Ph.D., Director
Sidney Taurel, Chairman of the Board/Director
George M. C. Fisher, Director
Dr.Martin S. Feldstein, Ph.D., Director
J. Michael Cook, Director
Sir Winfried F. W. Bischoff, Director
Financials
Quarterly
Annual
| Income Statement | 04/2008 | 01/2008 | 10/2007 | 08/2007 |
|---|---|---|---|---|
| Sales | 1.11 Bil. | 1.27 Bil. | 789.1 Mil. | 736.4 Mil. |
| Gross Operating Profit | 3.7 Bil. | 3.92 Bil. | 3.8 Bil. | 3.89 Bil. |
| Operating Income before D & A (EBITDA) | 1.27 Bil. | 1.21 Bil. | 1.48 Bil. | 1.52 Bil. |
| Total Income Before Interest Expenses (EBIT) | 1.06 Bil. | 1.14 Bil. | 1.23 Bil. | 985.8 Mil. |
| Total Net Income | 1.06 Bil. | 854.4 Mil. | 926.3 Mil. | 663.6 Mil. |
| Basic EPS, Total | 0.97 | 0.78 | 0.85 | 0.61 |
| Diluted EPS, Total | 0.97 | 0.78 | 0.85 | 0.61 |
| BALANCE STATEMENT | 04/2008 | 01/2008 | 10/2007 | 08/2007 |
|---|---|---|---|---|
| Cash and Equivalents | NA | NA | 2.5 Bil. | 2.22 Bil. |
| Total Assets | NA | NA | 10.45 Bil. | 9.56 Bil. |
| Total Liabilities | NA | NA | 4.07 Bil. | 4.55 Bil. |
| Total Capitalization | NA | NA | 17.48 Bil. | 16.13 Bil. |
| Cash Flow | 04/2008 | 01/2008 | 10/2007 | 08/2007 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | NA | 2.92 Bil. | 1.48 Bil. |
| Net Cash From Investing Activities | NA | NA | -3.26 Bil. | -2.61 Bil. |
| Net Cash From Financing Activities | NA | NA | -354.2 Mil. | 219 Mil. |
| Net Change in Cash & Cash Equivalents | NA | NA | -613.8 Mil. | -888.8 Mil. |
| Income Statement | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Sales | 4.25 Bil. | 2.74 Bil. | 2.75 Bil. | 2.63 Bil. |
| Gross Operating Profit | 14.38 Bil. | 12.95 Bil. | 11.9 Bil. | 11.23 Bil. |
| Operating Income before D & A (EBITDA) | 4.8 Bil. | 4.93 Bil. | 4.38 Bil. | 4.26 Bil. |
| Total Income Before Interest Expenses (EBIT) | 3.89 Bil. | 3.66 Bil. | 2.82 Bil. | 2.99 Bil. |
| Total Net Income | 295.3 Bil. | 2.66 Bil. | 1.98 Bil. | 1.81 Bil. |
| Basic EPS, Total | 2.71 | 2.45 | 1.82 | 1.67 |
| Diluted EPS, Total | 2.71 | 2.45 | 1.81 | 1.66 |
| BALANCE STATEMENT | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Cash and Equivalents | NA | 3.11 Bil. | 3.01 Bil. | 5.37 Bil. |
| Total Assets | NA | 9.69 Bil. | 10.8 Bil. | 12.84 Bil. |
| Total Liabilities | NA | 5.09 Bil. | 5.72 Bil. | 7.59 Bil. |
| Total Capitalization | NA | 14.48 Bil. | 16.56 Bil. | 15.41 Bil. |
| Cash Flow | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | 3.98 Bil. | 1.91 Bil. | 2.87 Bil. |
| Net Cash From Investing Activities | NA | 608.4 Mil. | -2.22 Bil. | -684.8 Mil. |
| Net Cash From Financing Activities | NA | -4.58 Bil. | -1.88 Bil. | 203.7 Mil. |
| Net Change in Cash & Cash Equivalents | NA | 102.6 Mil. | -2.36 Bil. | 2.61 Bil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
54.72 Bil.
63.75 Bil.
45.45 Bil.
30.81 Bil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- If you have a change request regarding a publicly traded company, click here
- If your request pertains to a private company, click here
Also in Portfolio.com
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.


